Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Review › Forskning › peer review
Functional assessment of hepatobiliary secretion by 11C-cholylsarcosine positron emission tomography. / Ørntoft, Nikolaj; Frisch, Kim; Ott, Peter; Keiding, Susanne; Sørensen, Michael.
I: B B A - Molecular Basis of Disease, Bind 1864, Nr. 4, Part B, 04.2018, s. 1240-1244.Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Review › Forskning › peer review
}
TY - JOUR
T1 - Functional assessment of hepatobiliary secretion by 11C-cholylsarcosine positron emission tomography
AU - Ørntoft, Nikolaj
AU - Frisch, Kim
AU - Ott, Peter
AU - Keiding, Susanne
AU - Sørensen, Michael
N1 - Copyright © 2017 Elsevier B.V. All rights reserved.
PY - 2018/4
Y1 - 2018/4
N2 - Positron emission tomography (PET) with 11C-cholylsarcosine (11C-CSar), a radiolabelled synthetic N-methylglycine (sarcosine) conjugate of cholic acid, is a novel molecular imaging technique that enables quantitative assessment of the individual transport steps involved in hepatic secretion of conjugated bile acids. Here, we present the method and discuss its potential clinical and scientific applications based on findings in the first human study of healthy subjects and patients with cholestasis. We also present a clinical example of a patient studied during and six months after an episode of drug-induced cholestatic liver injury.
AB - Positron emission tomography (PET) with 11C-cholylsarcosine (11C-CSar), a radiolabelled synthetic N-methylglycine (sarcosine) conjugate of cholic acid, is a novel molecular imaging technique that enables quantitative assessment of the individual transport steps involved in hepatic secretion of conjugated bile acids. Here, we present the method and discuss its potential clinical and scientific applications based on findings in the first human study of healthy subjects and patients with cholestasis. We also present a clinical example of a patient studied during and six months after an episode of drug-induced cholestatic liver injury.
KW - Journal Article
KW - Review
U2 - 10.1016/j.bbadis.2017.11.016
DO - 10.1016/j.bbadis.2017.11.016
M3 - Review
C2 - 29197661
VL - 1864
SP - 1240
EP - 1244
JO - B B A - Molecular Basis of Disease
JF - B B A - Molecular Basis of Disease
SN - 0925-4439
IS - 4, Part B
ER -